LabCorp to buy Covance to enter clinical trials business | Business Information & News | Westlaw

LabCorp to buy Covance to enter clinical trials business | Business Information & News | Westlaw

View on Westlaw or start a FREE TRIAL today, LabCorp to buy Covance to enter clinical trials business, Business Information & News
11/3/14 REUTERS 20:34:48
REUTERS
Copyright © 2014 Thomson Reuters
November 3, 2014
LabCorp to buy Covance to enter clinical trials business
Natalie Grover
Ankur Banerjee
(Reuters) - Laboratory Corp of America Holdings, a major provider of healthcare diagnostic services, said it would buy Covance Inc for about $6.1 billion in cash and stock to expand into the contract clinical trial business.
LabCorp and larger rival...
---- Index References ----
Company: WELLS FARGO SECURITIES LLC; LAZARD LTD; LABORATORY CORPORATION OF AMERICA HLDGS; MERRILL LYNCH AND CO INC; GOLDMAN SACHS AND CO; CRAVATH SWAINE AND MOORE LLP; COVINGTON AND BURLING LLP; SULLIVAN AND CROMWELL LLP; WELLS FARGO BANK NA; QUEST DIAGNOSTICS INC
News Subject: (Major Corporations (1MA93); Equity Instruments (1EQ90); Corporate Groups & Ownership (1XO09); Corporate Events (1CR05); Mergers & Acquisitions (1ME39); Funding Instruments (1FU41); Business Management (1BU42))
Industry: (Clinical Laboratory (1CL83); Financial Services (1FI37); Healthcare Services (1HE13); Banking (1BA20); Securities Investment (1SE57); Stocks (1EQ09); Investment Management (1IN34); Healthcare (1HE06))
Region: (Singapore (1SI94); Far East (1FA27); Asia (1AS61); Southeast Asia (1SO64); Eastern Asia (1EA61))
Language: EN
Other Indexing: (LabCorp) (David King; Tim Chong; Michael Cherny)
Keywords: securities; ma (MCC:f); (N2:US); (N2:AMERS); (N2:USA); (MCCL:OVR); (MCCL:OEC)
Word Count: 472
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.